AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Year-over-year SG&A expense growth
5Y CAGR
-10.5%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 12.45% |
| 2024 | 10.59% |
| 2023 | 2.26% |
| 2022 | -2.25% |
| 2021 | 9.73% |
| 2020 | 21.70% |
| 2019 | 22.20% |
| 2018 | 21.48% |
| 2017 | 15.18% |
| 2016 | 18.24% |